"First vaccine targeting SARS virus family enters human trials"

"First vaccine targeting SARS virus family enters human trials"

A new vaccine, GBP511 developed by UW Medicine, has entered clinical trials in Australia. It aims to protect against COVID-19 and related coronaviruses, including potential future threats, with trials led by South Korean pharmaceutical company SK Bioscience.

#COVID19

Source: https://www.ipd.uw.edu/2026/02/gbp511-vaccine-clinical-trial-begins/